Patent · US Active

Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

US8841330B2 · kind B2 · utility

8Cited by

242References

14Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Bernd Riedl · Wuppertal, DE
Jacques Dumas · Neuilly-Plaisance, FR
Uday Khire · Hamden, US
Timothy B. Lowinger · Carlisle, US
William Scott · Guilford, US
Roger Smith · Madison, US
Jill Wood · Hampton, US

Key dates

Filing date	Feb 8, 2012
Grant date	Sep 23, 2014
Priority date	—
Expiry date	Feb 8, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.